C07C 235/18
Having at least one of the singly-bound oxygen atoms further bound to
Official title: having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
C07C235/18 (Having at least one of the singly-bound oxygen atoms further bound to) appears on 373 US grants and 396 published applications in this corpus.
Search patents in C07C- Granted patents
- 373
- Published applications
- 396
- Assignees
- 233
- Inventors
- 1,227
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 10 | 0 |
| 1999 | 17 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 3 |
| 2002 | 28 | 17 |
| 2003 | 15 | 32 |
| 2004 | 19 | 15 |
| 2005 | 7 | 24 |
| 2006 | 11 | 26 |
| 2007 | 16 | 18 |
| 2008 | 12 | 20 |
| 2009 | 14 | 17 |
| 2010 | 13 | 13 |
| 2011 | 9 | 15 |
| 2012 | 13 | 10 |
| 2013 | 14 | 10 |
| 2014 | 12 | 14 |
| 2015 | 5 | 16 |
| 2016 | 17 | 12 |
| 2017 | 9 | 12 |
| 2018 | 9 | 8 |
| 2019 | 5 | 15 |
| 2020 | 15 | 20 |
| 2021 | 9 | 18 |
| 2022 | 13 | 11 |
| 2023 | 13 | 15 |
| 2024 | 5 | 17 |
| 2025 | 7 | 11 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Capsaicin analogs and uses thereof29 Sep 2026US 12,747,200 B2Young BioPharma, LLC
- Isotopic thyromimetic compounds22 Sep 2026US 12,741,932 B2Autobahn Therapeutics, Inc.
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Compound having malate dehydrogenase inhibitory activity and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient19 May 2026US 12,630,497 B2Dongguk University Industry-Academic Cooperation Foundation
- Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition for suppressing cancer growth comprising same as active ingredient27 Jan 2026US 12,534,436 B2Onecuregen Co., Ltd.
- Noncovalent Keap1-Nrf2 Small-Molecule Inhibitors9 Jul 2026US 2026/0193170 A1University of Copenhagen
- Tertiary amide aldonamide based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation28 May 2026US 2026/0146239 A1PanTHERA CryoSolutions Inc.
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Sirtuin modulating compounds, including sirtuin activating compounds, and applications thereof23 Apr 2026US 2026/0109713 A1
- Compositions and methods for treating cancer26 Mar 2026US 2026/0085074 A1The Regents of the University of California
Most cited
By later US patents
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Compounds and compositions for delivering active agents125US 5,866,536 AEmisphere Technologies, Inc. · 1999
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998
- Selective androgen receptor modulators and methods of use thereof113US 6,569,896 B2The University of Tennessee Research Corporation · 2003
- Selective androgen receptor modulators and methods of use thereof92US 6,492,554 B2The University of Tennessee Research Corporation · 2002